unknown
Stage
2
Investors
About
Agteria has developed a patent-pending molecule designed to significantly reduce methane emissions from cattle. The company presents the solution as scalable and low-cost for reducing enteric methane.
Explore Agteria's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.